Steven Valiquette

Q: What is Steven Valiquette's success rate?

Steven Valiquette currently has a success rate of 85.096124829943.

Q: What is the average return of Steven Valiquette's calls?

Their stock ratings have generated an average return of 5.341044624431096.

Mizuho | Healthcare

Steven Valiquette is an analyst from Mizuho specializing in the Healthcare sector. Ranked #1860 out of 4525 analysts, they have issued 27 stock ratings with a success rate of 85.10% and an average return of 5.34%.

Steven Valiquette has a well-established track record, with 27 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 85.10% and an average return of 5.34%, underscoring their expertise and ability to identify winning opportunities for investors.

#1860

Out of 4525

Total Ratings

+85.10%

Success Rate

+5.34%

Average Return

Recent Ratings Analysis

NVST

Hold

Jan 20, 2026

Target

$24.00

Current

$24.34

Performance

0.00%

Steven Valiquette rated NVST as Neutral on Jan 20, 2026, setting a price target of 24. The Hold stance appears justified, as shares hovered around 24.34 with a 0.00% move.

SOLV

Buy

Jan 20, 2026

Target

$100.00

Current

$78.96

Performance

0.00%

On Jan 20, 2026, SOLV was given a Outperform rating by Steven Valiquette, with a target price of 100. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

HSIC

Hold

Jan 20, 2026

Target

$81.00

Current

$77.73

Performance

0.00%

HSIC received a Neutral rating from Steven Valiquette on Jan 20, 2026, aiming for 81. Shares remained flat at 77.73, aligning with the neutral rating.

ALGN

Buy

Jan 20, 2026

Target

$200.00

Current

$165.55

Performance

0.00%

On Jan 20, 2026, Steven Valiquette published a Outperform outlook on ALGN, with a target of 200. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 165.55.

XRAY

Hold

Jan 20, 2026

Target

$14.00

Current

$12.05

Performance

0.00%

Steven Valiquette on Jan 20, 2026 assigned XRAY a Neutral rating, with a price target of 14. The Hold stance reflected consolidation, as shares held near 12.05.

MDLN

Buy

Jan 12, 2026

Target

$48.00

Current

$44.15

Performance

3.35%

On Jan 12, 2026, Steven Valiquette reaffirmed MDLN with a Outperform rating, targeting 48. Market indecision has kept the 48 target in a holding pattern.

PHR

Buy

Dec 10, 2025

Target

$36.00

Current

$15.73

Performance

-0.32%

PHR was rated Outperform by Steven Valiquette on Dec 10, 2025, with a price objective of 36. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

LFMD

Hold

Nov 19, 2025

Target

$6.00

Current

$3.56

Performance

-10.78%

On Nov 19, 2025, Steven Valiquette initiated coverage on LFMD with a Neutral rating and target of 6. The rating matched the stock’s inability to hold above 3.56.

GDRX

Hold

Nov 06, 2025

Target

$4.00

Current

$2.60

Performance

-17.72%

Steven Valiquette issued a Neutral recommendation for GDRX on Nov 06, 2025, price target set at 4. Market action validated the conservative Hold outlook with shares at 2.6.

COR

Buy

Nov 06, 2025

Target

$380.00

Current

$350.67

Performance

-2.66%

On Nov 06, 2025, COR was evaluated by Steven Valiquette, who gave a Outperform rating and target of 380. So far, the Buy call awaits clearer momentum, with shares flat at 350.67.

CAH

Buy

Nov 04, 2025

Target

$210.00

Current

$210.37

Performance

7.69%

Steven Valiquette rated CAH as Outperform on Nov 04, 2025, setting a price target of 210. The call has proven timely, with shares rising 7.69% toward the price target of 210.

WAY

Buy

Oct 30, 2025

Target

$50.00

Current

$29.74

Performance

-19.75%

On Oct 30, 2025, WAY was given a Outperform rating by Steven Valiquette, with a target price of 50. Despite the Buy call, shares fell from 29.74 to 29.74, challenging the optimistic stance.

MCK

Hold

Sep 24, 2025

Target

$770.00

Current

$821.84

Performance

8.05%

MCK received a Neutral rating from Steven Valiquette on Sep 24, 2025, aiming for 770. Investors saw gains of 8.05% that the cautious stance didn’t fully capture.

VEEV

Buy

Aug 29, 2025

Target

$325.00

Current

$216.26

Performance

-19.67%

On Aug 29, 2025, Steven Valiquette published a Outperform outlook on VEEV, with a target of 325. Market action contradicted the Buy thesis, as shares slipped to 216.26.

TDOC

Hold

Jul 25, 2025

Target

$10.00

Current

$6.07

Performance

-25.98%

Steven Valiquette on Jul 25, 2025 assigned TDOC a Neutral rating, with a price target of 10. The call successfully avoided chasing as shares lost 25.98%.

DOCS

Hold

Feb 10, 2025

Target

$65.00

Current

$41.10

Performance

-50.57%

On Feb 10, 2025, Steven Valiquette reaffirmed DOCS with a Neutral rating, targeting 65. The Hold stance reflected market caution that was later justified.

TALK

Buy

Dec 04, 2024

Target

$5.00

Current

$3.77

Performance

4.43%

TALK was rated Outperform by Steven Valiquette on Dec 04, 2024, with a price objective of 5. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

HQY

Buy

Dec 04, 2024

Target

$126.00

Current

$84.00

Performance

-18.45%

On Dec 04, 2024, Steven Valiquette initiated coverage on HQY with a Outperform rating and target of 126. The Buy call has yet to be validated as shares remain 42.00 away from the target.

Frequency Asked Questions

Who is Steven Valiquette?

Steven Valiquette is an analyst from Mizuho specializing in the Healthcare sector.

What is Steven Valiquette's success rate?

Steven Valiquette currently has a success rate of +85.10%.

How many ratings has Steven Valiquette issued?

Steven Valiquette has issued 27 stock ratings so far.

What is the average return of Steven Valiquette's calls?

Their stock ratings have generated an average return of +5.34%.

What is Steven Valiquette's ranking?

Steven Valiquette is ranked #1860 out of 4525 analysts.

What types of ratings does Steven Valiquette give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Steven Valiquette?

You can follow Steven Valiquette by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Steven Valiquette?

Their latest rating was a Hold on NVST issued on 2026-01-20.